Epidemiological aspects of the incidence and mortality of cervical cancer (literature review)

Cover Page

Cite item

Full Text

Abstract

A review of domestic and foreign literature was carried out. Statistical analysis of the available literature showed that at present, despite the improvement of screening programs around the world, there is a steady increase in the incidence and mortality of cervical cancer in women of reproductive age with a high percentage of patients with advanced forms, whose proportion is 32 %. The percentage of deaths during the year since the verification of the disease in 2020 was 12.6 %.

In the structure of mortality in the Russian population, malignant diseases occupy the second ranking place, accounting for 13.6 % after diseases of the cardiovascular system – 43.9 %. Diseases of the female reproductive system account for 18.2 %. At the same time, cervical cancer in the overall structure of oncological morbidity occupies the 4th ranking place, and among the organs of the reproductive system – the 2nd place – 13.3 %, yielding to breast cancer (47.8 %). These figures reflect the lack of implemented programs aimed at reducing the incidence of cervical cancer.

About the authors

G. Z. Kulieva

A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiology Center, Ministry of Health of Russia

Author for correspondence.
Email: gunelka2010@yandex.ru
ORCID iD: 0000-0001-7585-7998

Gunel Zakir kyzy Kulieva

10 Marshala Zhukova St., Obninsk 249036

Russian Federation

L. S. Mkrtchyan

A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiology Center, Ministry of Health of Russia

10 Marshala Zhukova St., Obninsk 249036

Russian Federation

L. I. Krikunova

A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiology Center, Ministry of Health of Russia

10 Marshala Zhukova St., Obninsk 249036

Russian Federation

S. A. Ivanov

A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiology Center, Ministry of Health of Russia; Рeoples’ Friendship University of Russia

10 Marshala Zhukova St., Obninsk 249036; 6 Miklukho-Maklaya St., Moscow 117198

Russian Federation

A. D. Kaprin

Рeoples’ Friendship University of Russia; National Medical Research Radiology Center, Ministry of Health of Russia; P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia

ORCID iD: 0000-0001-8784-8415

6 Miklukho-Maklaya St., Moscow 117198; 10 Marshala Zhukova St., Obninsk 249036; 2-oy Botkinskiy Proezd, Moscow 125284

Russian Federation

References

  1. Zhang S., Xu H., Zhang L., Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 2020;32(6):720–28. doi: 10.21147/j.issn.1000-9604.2020.06.05
  2. Choi S., Ismail A., Pappas-Gogos G., Boussios S. HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens 2023;12:298. doi: 10.3390/pathogens12020298
  3. Nygård M., Nygård S. The future of cervical cancer prevention: from “one-size-fits-all” to personalized screening. J Pers Med 2023;13:161. doi: 10.3390/jpm13020161
  4. Gopu P., Antony F., Cyriac S. et al. Updates on systemic therapy for cervical cancer. Ind J Med Res 2021;154(2):293–302. doi: 10.4103/ijmr.IJMR_4454_20
  5. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6): 394–424. doi: 10.3322/caac.21492
  6. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209–49. doi: 10.3322/caac.21660
  7. Arbyn M., Weiderpass E., Bruni L. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8(2):191–203. doi: 10.1016/s2214-109X(19)30482-6
  8. Fowler J.R., Maani E.V., Dunton C.J., Jack B.W. Cervical Cancer. 2022. Treasure Island: StatPearls Publishing, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK431093/.
  9. Singh D., Vignat J., Lorenzoni V. et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2023;11(2):197–206. doi: 10.1016/S2214-109X(22)00501-0
  10. Ferlay J., Ervik M., Lam F. et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. Available at: https://gco.iarc.fr/today.
  11. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34. doi: 10.3322/caac.21551
  12. Shrestha A.D., Neupane D., Vedsted P., Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev 2018;19(2):319–24. doi: 10.22034/APJCP.2018.19.2.319
  13. Lemp J.M., De Neve J.W., Bussmann H. et al. Lifetime prevalence of cervical cancer screening in 55 lowand middle-income countries. JAMA 2020;324(15):1532–42. doi: 10.1001/jama.2020.16244
  14. Singh G.K., Azuine R.E., Siahpush M. Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. Int J Mch Aids 2012;1(1):17–30. doi: 10.21106/ijma.12
  15. Broberg G., Wang J., Östberg A.L. et al. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study. PLoS One 2018;13(1):e0190171. doi: 10.1371/journal.pone.0190171
  16. Endale H., Mulugeta T., Habte T. The socioeconomic impact of cervical cancer on patients in ethiopia: evidence from Tikur Anbessa Specialized Hospital. Cancer Manag Res 2022;14:1615– 25. doi: 10.2147/CMAR.S352389
  17. Akinyemiju T., Ogunsina K., Sakhuja S. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO’s Study on Global Ageing and Adult Health (SAGE). BMJ Open 2016;6:012753. doi: 10.1136/bmjopen-2016-012753
  18. Xu T., Yang X., He X. The study on cervical cancer burden in 127 countries and its socioeconomic influence factors. J Epidemiol Glob Health 2023;13:154–61. doi: 10.1007/s44197-022-00081-1
  19. Hull R., Mbele M., Makhafola T. et al. Cervical cancer in low and middleincome countries (review). Oncol Lett 2020;20:2058–74.
  20. Bhatla N., Berek J.S., CuelloFredes M. et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019;145(1):129–35. doi: 10.1002/ijgo.12749
  21. Koh W.J., Abu-Rustum N.R., Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(1):64–84. doi: 10.6004/jnccn.2019.0001
  22. Malignant neoplasms in Russia in 2019 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2020. 250 p. (In Russ.)
  23. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. M.: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2021. 252 p. (In Russ.)
  24. The state of oncological care for the population of Russia in 2021, Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.)
  25. Krikunova L.I. Radiation therapy for cervical cancer. Prakticheskaya onkologiya = Practical Oncology 2002;3(3):194–9. (In Russ.)
  26. Bohman Ya.V. Guide to oncogynecology. Leningrad: Meditsina, 1989. Pp. 164–172. (In Russ.)
  27. Polyakova V.A. Oncogynecology. Guide for doctors. Moscow: Meditsinskaya kniga, 2001. 152 p. (In Russ.)
  28. Leonov M.G., Shelyakina T.V., Lukyanova L.V., Chernov S.N. Historical aspects of cytological screening for cervical cancer. Volgogradskiy nauchno-medicinskiy zhurnal = Volgograd Medical Scientific Journal 2012;36(4):6–11. (In Russ.)
  29. Mkrtchyan L.S., Kaprin A.D., Ivanov S.A. et al. Efficiency of treatment of locally advanced cervical cancer depending on prognostic factors. Voprosy onkologii = Oncology Issues 2019;65(4):584–9. (In Russ.)
  30. Mkrtchyan L.S. Chemoradiation treatment of locally advanced cervical cancer and prognostic factors. Thesis … doctor of medical sciences. Obninsk, 2019. 328 p. (In Russ.)
  31. Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical guidelines for the drug treatment of cervical cancer. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2018;8(3s2):178–89. Available at: https://www.rosoncoweb.ru/standards/RUSSCO/2018/2018-12.pdf. (In Russ.)
  32. Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical recommendations for the drug treatment of cancer of the cervix. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2020;10(3s2):221–41. Available at: https://rosoncoweb.ru/standards/RUSSCO/2020/2020-13.pdf. (In Russ.)
  33. Cervical Cancer. Clinical recommendations of the Association of Oncologists of Russia. Moscow: Ministry of Health of Russia, 2019. 66 p. (In Russ.)
  34. Каприн А.Д., Мардынский Ю.С. Терапевтическая радиология. Национальное руководство. М.: ГЭОТАР-Медиа, 2018. 704 с. Kaprin A.D., Mardynskiy Yu.S. Therapeutic radiology. National leadership. Moscow: GEOTAR-Media, 2018. 704 p. (In Russ.)
  35. Khokhlova S.V., Dengina N.V., Kolomiets L.A. et al. Practical recommendations for the drug treatment of cancer of the cervix. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2017;7(3s2):158–67. Available at: https://www.rosoncoweb.ru/ standards/RUSSCO/2017/recoms2017_11.pdf. (In Russ.)
  36. World Health Organization (WHO). WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. Geneva: World Health Organization, 2018. Available at: https://www.who.int/news/item/18-05-2018-who-dgcalls-for-all-countries-to-take-action-to-help-end-the-sufferingcaused-by-cervical-cancer.
  37. World Health Organization (WHO). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization, 2020.
  38. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization, 2021.
  39. Brisson M., Kim J.J., Canfell K. et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lowermiddle-income countries. Lancet 2020;395(10224):575–90. doi: 10.1016/S0140-6736(20)30068-4
  40. Canfell K., Kim J.J., Brisson M. et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lowermiddle-income countries. Lancet 2020;395(10224):591–603. doi: 10.1016/S0140-6736(20)30157-4.
  41. Bruni L., Saura-Lázaro A., Montoliu A. et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med 2021;144(106399):1–11. doi: 10.1016/j.ypmed.2020.106399
  42. Briolat J., Dalstein V., Saunier M. et al. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007;121(10):2198–204. doi: 10.1002/ijc.22959
  43. Shipulina O.Yu. Epidemiological features and measures for the prevention of oncogynecological pathology of papillomavirus etiology. Thesis … candidate of medical sciences. Moscow, 2013. 24 p. (In Russ.)
  44. Protasova A.E. Cervical intraepithelial neoplasia and cervical cancer. Is human papillomavirus the only risk factor? Effektivnaya farmakoterapiya = Effective pharmacotherapy 2019;15(32):42–6. (In Russ.). doi: 10.33978/2307-3586-2019-15-32-42-46
  45. ARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. Lyon, 2007. 636 p.
  46. Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12–9. doi: 10.1002/(SICI)10969896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  47. Bruni L., Albero G., Serrano B. et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World, 2021. 314 p.
  48. Ashamalla H., Ashamalla M., McFarlane S.I. COVID-19 pandemic and the new state of oncology practice: an editorial. Am J Med Case Rep 2020;8(9):311, 312. doi: 10.12691/ajmcr-8-9-13
  49. Maringe C., Spicer J., Morris M. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020;21(8):1023–34. doi: 10.1016/S1470-2045(20)30388-0
  50. Chino J., Annunziata C.M., Beriwal S. et al. The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes. Gynecol Oncol 2020;159(3):607–10. doi: 10.1016/j.ygyno.2020.09.015

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.